Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Réglementation et droit · 28/12/20211 min de lecture
Prospective Grant of Exclusive Patent License: “Griffithsin Compositions for Treatment and Prevention of Anti-Viral Infections”
Traduction automatique locale · Langue originale de la source
Résumé
The National Cancer Institute (NCI), National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to University of Louisville Research Foundation, ("ULRF") in its rights to the inventions and patents listed in the Supplementary Information section of this notice. ULRF is a Kentucky 501(c)3 non-profit corporation that is the agent of the University of Louisville ("UofL") for licensing intellectual property owned and controlled by ULRF on behalf of UofL.
Langue originale de la source: Federal Register — All DocumentsOuvrir le communiqué original →